Lung Cancer
Volume 45 , Pages S29-S33 , August 2004

Pathological anatomy and molecular pathology

References 

  1. Huzly A. Parietale pleurektomie bei der sekundären pleurakarzinose. Z. Herz-Thorax-Gefäßchir. 1989;3:80–83
  2. Hammar SP. Pleural Neoplasms. In: Dail DH, Hammar SP, editors. Pulmonary pathology. 2nd ed. New York: Springer. p. 1487–1571.
  3. Baris I, Artvinli M, Sahin AA. Environmental mesothelioma in Turkey. Ann. N. Y. Acad. Sci. 1979;330:432
  4. Tagnon I, Blot WJ, Stroube RB, Day NE, Morris LE, Peace BB, et al.  Mesothelioma associated with the shipbuilding industry in coastal Virginia. Cancer Res. 1980;40:3875–3879
  5. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, et al.  Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994;9:1781–1790
  6. Mutti L, Carbone M, Giordano GG, Giordano A. Simian virus 40 and human cancer. Monaldi Arch. Chest Dis. 1998;53:198–201
  7. Shivapurkar N, Wiethege T, Wistuba II, Salomon E, Milchgrub S, Müller KM, et al.  Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J. Cell Biochem. 1990;76:181–188
  8. Mark J. Monosomy 14, monosomy 22 and 13q—three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques. Acta Cytol. 1978;22:398–401
  9. Popescu NC, Chahinian AP, DiPaolo JA. Nonrandom chromosome alterations in human malignant mesothelioma: DNA cytometry and comparative genomic. Cancer Res. 1988;48:142–147
  10. Krismann M, Müller KM, Jaworska M, Johnen G. Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases. J. Pathol. 2002;197:363–371
  11. Bjorkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S. Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q, and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br. J. Cancer. 1997;75:523–527
  12. Bjorkqvist AM, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K, et al.  Comparison of DNA copy number changes in malignant mesothelioma , adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br. J. Cancer. 1998;77:260–269
  13. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, et al.  DNA copy number losses in human neoplasms. Am. J. Pathol. 1999;155:683–694
  14. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K, Knuutila S. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br. J. Cancer. 1989;60:618–626
  15. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, and in collaboration with LH Sobin and pathologists from 14 countries. Histological classification of lung and pleural tumours. 3rd ed. Berlin, Heidelberg, New York: Springer; 1999.
  16. Battifora H, McCaughey WTE. Tumours of the serosal membranes. 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 1995.
  17. Nascimento AG, Keeney GL, Fletcher CD. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am. J. Surg. Pathol. 1994;18:439–445
  18. Donna A, Betta PG. Mesodermomas: a new embryological approach to primary tumours of coelomic surfaces. Histopathology. 1982;5:31–44
  19. Donna A, Betta PG. Differentiation towards cartilage and bone in a primary tumour of pleura. Further evidence in support of the concept of mesodermoma. Histopathology. 1986;10:101–108
  20. Donna A, Betta PG, Bianchi V, Ribotta M, Bellingeri D, Robutti F, et al.  A new insight into the histogenesis of “mesodermomas”—malignant mesotheliomas. Histopathology. 1991;19:239–244
  21. Krismann M, Jaworska M, Müller KM, Johnen G. Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features—CGH evidence for a mesothelioma subgroup. J. Mol. Diagn. 2000;2:209–216
  22. Müller KM. Mesotheliome–Pathologie/Pathogenese/Mesotheliomregister. Pneumologie. 1997;51:335–344
  23. Kumaki F, Kawai T, Churg A, Galateau-Salle FB, Hasleton P, Henderson D, et al.  Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am. J. Surg. Pathol. 2002;26:365–370
  24. Motherby H, Marcy T, Hecker M, Ross B, Nadjari B, Auer H, et al.  Static DNA cytometry as a diagnostic aid in effusion cytology. I. DNA aneuploidy for identification and differentiation of primary and secondary tumours of the serous membranes. Anal. Quant. Cytol. Histol. 1998;20:153–161
  25. Jones JS. The formation and function of the Mesothelioma Panel of the Commission of the European Communities. Commission of the European Communities. Brussels: Office for Official Publications of the European Communities; 1993.

PII: S0169-5002(04)00168-0

doi: 10.1016/j.lungcan.2004.04.005

Lung Cancer
Volume 45 , Pages S29-S33 , August 2004

Article Tools